Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

PROCEPT BioRobotics PRCT stock is trading on Monday after the company released better-than-expected third-quarter earnings. The company reported EPS loss of $(0.40), down from$(0.51) a year ago, beating the consensus loss of $(0.49). The surgical robotics company reported third-quarter sales of$58.4 million, up 66.3% year-over-year, beating the consensus of $53.18 million. The increase was primarily driven by increased system sales, higher average selling prices, and increased handpiece and other consumab ...